Bladder

Philadelphia Mass Tort Litigation Concerning Janssen Bladder Medication Concludes Without Key Bellwether Trial

by

Philadelphia — A significant legal battle involving the pharmaceutical company Janssen Pharmaceuticals over its bladder drug has concluded without proceeding to a bellwether trial, marking a notable development in mass tort litigations. The case centered around allegations that Janssen’s medication, which was intended to treat bladder conditions, caused severe side effects which were not adequately disclosed to patients. Over recent years, numerous patients had come forward with claims that the drug resulted in debilitating complications, spurring a series of lawsuits. Legal experts had anticipated that a bellwether trial would set precedents for the resolution of … Read more

Groundbreaking Resolution Reached as Philadelphia Mass Tort Case Against Janssen’s Bladder Drug Concludes Successfully

by

PHILADELPHIA, PA – A mass tort case against pharmaceutical company Janssen over its bladder drug is coming to a close without a jury verdict. The trial had begun in late October with sixty-two plaintiffs alleging that Janssen’s drug had caused them harm. However, the case was recently settled for an undisclosed amount, marking the end of the litigation. The lawsuit was filed in the Philadelphia Court of Common Pleas, where thousands of other lawsuits related to the drug have been consolidated as part of a mass tort program. The plaintiffs claimed that Janssen failed to … Read more

Philadelphia Mass Tort Over Bladder Drug Concludes Without Bellwether Trial, Confidential Settlements Reached

by

Philadelphia’s coordinated litigation over bladder medication Elmiron is coming to a close. The mass tort had its first trial scheduled to begin on Monday, but the majority of cases have been resolved through confidential settlements in the past six months. Tobi Millrood, partner at Kline & Specter and plaintiffs liaison counsel, provided this information. The Philadelphia mass tort involved numerous cases related to the use of Elmiron, a bladder medication. Confidential settlements have been reached for most of the cases in the program, leading to the cancellation of the bellwether trial. This trial would have … Read more